|
1
Hallinan, E.A., Hagen, T.J., Husa, R.K., et al. N-substituted dibenzoxazepines as analgesic PGE2 antagonists. J Med Chem 36 3293-3299 (1993).
2
Malmberg, A.B., Rafferty, M.F., Yaksh, T.L. Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci Lett 173 193-196 (1994).
3
Matsuo, M., Yoshida, N., Zaitsu, M., et al. Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089. Journal of Neuro-Oncology 66 285-292 (2004).
4
Carrasco, E., Casper, D., Werner, P. PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE2 neurotoxicity. J Neurosci Res 85 3109-3117 (2007).
5
Saleem, S., Li, R., Wei, G., et al. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J Neurosci Res 85(11) 2433-2440 (2007).
|